ambroxol has been researched along with Lung Neoplasms in 11 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the influence of perioperative intravenous administration of ambroxol on pulmonary function, postoperative complications, postoperative hospital stay, and cost after video-assisted thoracic surgery lobectomy for lung cancer." | 5.19 | [Effect of perioperative treatment with ambroxol on lung cancer patients after video-assisted thoracic surgery lobectomy]. ( Cheng, Y; Dong, S; Gao, Y; He, Z; Liang, L; Zhang, C; Zhou, W, 2014) |
| "To assess in a randomized clinical trial the influence of perioperative short-term ambroxol administration on postoperative complications, hospital stay and costs after pulmonary lobectomy for lung cancer." | 5.14 | Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy: a randomized trial. ( Brunelli, A; Di Nunzio, L; Refai, M; Sabbatini, A; Salati, M; Sciarra, V; Socci, L; Xiumé, F, 2009) |
| " Patients in the treatment group took ambroxol orally at a dosage of 90 mg, three times per day for 3 months from the beginning of radiotherapy." | 2.75 | The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor beta1 and tumor necrosis factor alpha. ( Dai, M; Mao, WD; Shen, WS; Shu, ZQ; Xi, L; Xia, DH; Xv, C; Yang, HZ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| He, W | 1 |
| Xiao, W | 1 |
| Zhang, X | 1 |
| Sun, Y | 1 |
| Chen, Y | 1 |
| Chen, Q | 1 |
| Fang, X | 1 |
| Du, S | 1 |
| Sha, X | 1 |
| Mehta, HJ | 1 |
| Mohammed, TL | 1 |
| Jantz, MA | 1 |
| Gao, Y | 1 |
| Cheng, Y | 1 |
| Dong, S | 1 |
| He, Z | 1 |
| Zhou, W | 1 |
| Liang, L | 1 |
| Zhang, C | 1 |
| Wang, X | 1 |
| Wang, L | 1 |
| Wang, H | 1 |
| Zhang, H | 1 |
| Wang, JY | 1 |
| Hong, X | 1 |
| Chen, GH | 1 |
| Li, QC | 1 |
| Liu, ZM | 1 |
| Li, J | 1 |
| Yi, W | 1 |
| Jiang, P | 1 |
| Sun, R | 1 |
| Li, T | 1 |
| Refai, M | 1 |
| Brunelli, A | 1 |
| Xiumé, F | 1 |
| Salati, M | 1 |
| Sciarra, V | 1 |
| Socci, L | 1 |
| Di Nunzio, L | 1 |
| Sabbatini, A | 1 |
| Xia, DH | 1 |
| Xi, L | 1 |
| Xv, C | 1 |
| Mao, WD | 1 |
| Shen, WS | 1 |
| Shu, ZQ | 1 |
| Yang, HZ | 1 |
| Dai, M | 1 |
| Ben, Y | 1 |
| Chen, J | 1 |
| Zhu, R | 1 |
| Gao, L | 1 |
| Bai, C | 1 |
| Salmona, M | 1 |
| Donnini, M | 1 |
| Perin, L | 1 |
| Diomede, L | 1 |
| Romano, M | 1 |
| Marini, MG | 1 |
| Tacconi, MT | 1 |
| Luisetti, M | 1 |
| Jabłonka, S | 1 |
| Ledwozyw, A | 1 |
| Jabłonka, A | 1 |
| Jurko, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Ambroxol on the Inflammatory Markers and Clinical Outcome of Patients With Diabetic Peripheral Neuropathy[NCT05558878] | 80 participants (Anticipated) | Interventional | 2022-10-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for ambroxol and Lung Neoplasms
| Article | Year |
|---|---|
[Effect of perioperative treatment with ambroxol on lung cancer patients after video-assisted thoracic surgery lobectomy].
Topics: Ambroxol; Humans; Length of Stay; Lung; Lung Neoplasms; Oxygen; Perioperative Period; Postoperative | 2014 |
Perioperative Lung Protection Provided by High-Dose Ambroxol in Patients with Lung Cancer.
Topics: Ambroxol; Anti-Bacterial Agents; Bacterial Infections; Expectorants; Female; Humans; Lung Neoplasms; | 2015 |
Mucosolvan serves to optimize perioperative airway management for NSCLC patients in fast track surgery: a randomized placebo controlled study.
Topics: Aged; Airway Management; Ambroxol; Carcinoma, Non-Small-Cell Lung; Expectorants; Female; Humans; Len | 2015 |
Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy: a randomized trial.
Topics: Aged; Ambroxol; Cost-Benefit Analysis; Female; Humans; Length of Stay; Lung Neoplasms; Male; Periope | 2009 |
The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor beta1 and tumor necrosis factor alpha.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ambroxol; Carbon Monoxide; Female; Free Radical Scavengers; Hu | 2010 |
6 other studies available for ambroxol and Lung Neoplasms
| Article | Year |
|---|---|
Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer.
Topics: Ambroxol; Animals; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Drug | 2020 |
Reclassify Lung-RADS Category "S".
Topics: Ambroxol; Early Detection of Cancer; Forests; Humans; Lung Neoplasms; Tomography, X-Ray Computed; Tr | 2017 |
Effects of ambroxol hydrochloride on concentrations of paclitaxel and carboplatin in lung cancer patients at different administration times.
Topics: Adult; Aged; Aged, 80 and over; Ambroxol; Antineoplastic Combined Chemotherapy Protocols; Carboplati | 2016 |
Upregulation of AQP3 and AQP5 induced by dexamethasone and ambroxol in A549 cells.
Topics: Adenocarcinoma; Ambroxol; Aquaporin 1; Aquaporin 3; Aquaporin 4; Aquaporin 5; Dexamethasone; Epithel | 2008 |
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer.
Topics: Adenocarcinoma; Ambroxol; Animals; Bronchoalveolar Lavage Fluid; Cell Membrane; Cell Survival; Human | 1992 |
[Effect of ambroxol on surfactant lipids in patients after resection of pulmonary tissue].
Topics: Adult; Aged; Ambroxol; Bromhexine; Humans; Lung Neoplasms; Male; Middle Aged; Premedication; Pulmona | 1989 |